Clinical Trials List
2023-09-27 - 2026-07-01
Phase III
Recruiting2
ICD-10E11.65
Type 2 diabetes mellitus with hyperglycemia
ICD-10E11.8
Type 2 diabetes mellitus with unspecified complications
ICD-9250.92
Diabetes with unspecified complication, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type, uncontrolled
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chung-Huei Hsu Division of Endocrinology
- 林彥宇 Division of Endocrinology
- Chen-Ling Huang Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
2700 participants
